Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for central neuropathic pain in MS
NCT00391079Phase 3Completed
- Sponsor
- GW Pharmaceuticals
- Start
- Sep 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in central neuropathic pain (CNP), sponsored by GW Pharmaceuticals. Started Sep 2006; status: completed.
02
Drugs
cannabidiol
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NCT00391079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391079.